搜索优化
English
全部
搜索
图片
视频
地图
资讯
Copilot
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
最新
最佳匹配
资讯
6 天
FDA取消自体CAR-T细胞免疫疗法风险评估与缓解策略(REMS)
2025年6月27日美国食品药品监督管理局 (FDA)宣布,取消当前已获批的BCMA及CD19靶向自体嵌合抗原受体 (CAR)T细胞免疫疗法的风险评估与缓解策略 (risk evaluation and mitigation strategy,REMS)要求。FDA认定无需REMS即可确保此类免疫疗法的安全性与有效性。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Birthright order blocked
Apologizes for racial slur
Bag sells for over $10M
Survives confidence vote
Tunnel collapses in LA
Launches Grok 4
To release web browser
Is Outlook down?
Hiker dies in Grand Canyon
Ousted PM indicted
Suffers serious injuries
Death ruled a homicide
Moo Deng's first birthday
Six agents suspended
Sentenced to 8+ years
Gets full FDA approval
US sanctions UN official
Ferrero to buy WK Kellogg
Utah judge sets execution
Takes over as PFL CEO
Reaches 1st Grand Slam final
Annual meeting in Nov
Makes first visit to Asia
Russian strikes on Kyiv
Copper tariffs to start Aug 1
US jobless claims fell
Booker gets max extension
Six firefighters injured
Unveils AI code of practice
Malaysia’s ex-PM turns 100
Bitcoin hits record high
反馈